Cannabis for Epilepsy Publications

[fusion_builder_container hundred_percent=”yes” overflow=”visible” padding_right=”30px” padding_left=”30px” ][fusion_builder_row][fusion_builder_column type=”1_1″ background_position=”left top” background_color=”” border_size=”” border_color=”” border_style=”solid” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”no” center_content=”no” min_height=”none”][vc_row full_width=”stretch_row_content_no_spaces” parallax=”content-moving” parallax_speed_bg=”3″ css=”.vc_custom_1475846772341{margin-top: -55px !important;margin-bottom: 0px !important;padding-top: 55px !important;padding-bottom: 110px !important;background-image: url(https://www.uttbio.com/wp-content/uploads/2016/08/Background_v2.jpg?id=14965) !important;background-position: center;background-repeat: no-repeat !important;background-size: cover !important;}”][vc_column][vc_custom_heading text=”Publications on Cannabis” font_container=”tag:h1|font_size:40|text_align:center|color:%23ffffff|line_height:36px” google_fonts=”font_family:Open%20Sans%3A300%2C300italic%2Cregular%2Citalic%2C600%2C600italic%2C700%2C700italic%2C800%2C800italic|font_style:300%20light%20regular%3A300%3Anormal”][vc_custom_heading text=”Browse through the history of medical cannabis research.” font_container=”tag:h2|font_size:18|text_align:center|color:%23ffffff” google_fonts=”font_family:Open%20Sans%3A300%2C300italic%2Cregular%2Citalic%2C600%2C600italic%2C700%2C700italic%2C800%2C800italic|font_style:300%20light%20regular%3A300%3Anormal” css=”.vc_custom_1472500486772{margin-bottom: 0px !important;}”][/vc_column][/vc_row][/fusion_builder_column][fusion_builder_column type=”1_1″ background_position=”left top” background_color=”” border_size=”” border_color=”” border_style=”solid” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”no” center_content=”no” min_height=”none”][vc_row full_width=”stretch_row_content” bg_type=”bg_color” bg_override=”full” bg_color_value=”#eff9ff” css=”.vc_custom_1472493612613{padding-right: 50px !important;padding-left: 50px !important;background-color: #ffffff !important;}”][vc_column width=”1/6″][vc_column_text]

1800 – 1939

[/vc_column_text][vc_separator border_width=”2″][vc_column_text]

1940 – 1942

[/vc_column_text][vc_separator border_width=”2″][vc_column_text]

1960 – 1969

[/vc_column_text][vc_separator border_width=”2″][vc_column_text]

Epilepsy

[/vc_column_text][vc_separator border_width=”2″][vc_column_text]

UTT BioPharma

[/vc_column_text][vc_separator border_width=”2″][/vc_column][vc_column width=”5/6″][vc_column_text]

Drug Resistant Epilepsy

[/vc_column_text][vc_separator border_width=”2″][vc_row_inner][vc_column_inner width=”1/6″][vc_single_image image=”15054″ img_size=”full” alignment=”center” style=”vc_box_shadow” onclick=”custom_link” link=”https://drive.google.com/file/d/0B5GR5Qf1tz0LTGYxOGM1U3M3UnM/view” css=”.vc_custom_1472636522164{margin-bottom: 15px !important;}”][vc_column_text]

The Lennox-Gastaut syndrome.
Beaumanoir, A., & Blume, W., 2005.

[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/6″][vc_single_image image=”15038″ img_size=”full” alignment=”center” style=”vc_box_shadow” onclick=”custom_link” link=”https://drive.google.com/file/d/0B5GR5Qf1tz0Lc0l0VzZlejRlN0k/view” css=”.vc_custom_1472633305291{margin-bottom: 15px !important;}”][vc_column_text]

The prevalence and demographic distribution of treated epilepsy.
D’Souza, W. J., Quinn et al, 2012.

[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/6″][vc_single_image image=”15039″ img_size=”full” alignment=”center” style=”vc_box_shadow” onclick=”custom_link” link=”https://drive.google.com/file/d/0B5GR5Qf1tz0LNzhsZllDMjRNMUE/view” css=”.vc_custom_1472633594316{margin-bottom: 15px !important;}”][vc_column_text]

Mechanisms of epileptogenesis: A convergence on neural circuit dysfunction.
Goldberg, E. M., & Coulter, D. A., 2013.

[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/6″][vc_single_image image=”15040″ img_size=”full” alignment=”center” style=”vc_box_shadow” onclick=”custom_link” link=”https://drive.google.com/file/d/0B5GR5Qf1tz0Lc3lLQVBCdmJsSUE/view” css=”.vc_custom_1472633861128{margin-bottom: 15px !important;}”][vc_column_text]

Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies.
Kwan, P., Arzimanoglou, et al. 2010.

[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/6″][vc_single_image image=”15041″ img_size=”full” alignment=”center” style=”vc_box_shadow” onclick=”custom_link” link=”https://drive.google.com/file/d/0B5GR5Qf1tz0LQ3VpRlRNOHVNTHM/view?usp=sharing” css=”.vc_custom_1472634071222{margin-bottom: 15px !important;}”][vc_column_text]

Understanding the basic mechanisms underlying seizures in mesial temporal lobe epilepsy and possible therapeutic targets: a review.
O’Dell, C. M., Das, A., Wallace et al. 2012.

[/vc_column_text][/vc_column_inner][/vc_row_inner][vc_column_text]

The endocannabinoid system and epileptogenesis

[/vc_column_text][vc_separator border_width=”2″][vc_row_inner][vc_column_inner width=”1/6″][vc_single_image image=”15042″ img_size=”full” alignment=”center” style=”vc_box_shadow” onclick=”custom_link” link=”http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1769341/” css=”.vc_custom_1472634471518{margin-bottom: 15px !important;}”][vc_column_text]

The endocannabinoid system controls key epileptogenic circuits in the hippocampus.
Monory, K., Massa, F., Egertová et al. 2006.

[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/6″][vc_single_image image=”15043″ img_size=”full” alignment=”center” style=”vc_box_shadow” onclick=”custom_link” link=”https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909018/pdf/nihms195711.pdf” css=”.vc_custom_1472634680417{margin-bottom: 15px !important;}”][vc_column_text]

Dynamic changes of CB1 receptor expression in hippocampi of epileptic mice and humans.
Maglóczky, Z., Tóth, K. et al. 2010.

[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/6″][vc_single_image image=”15044″ img_size=”full” alignment=”center” style=”vc_box_shadow” onclick=”custom_link” link=”https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1698282/pdf/nihms14036.pdf” css=”.vc_custom_1472634889179{margin-bottom: 15px !important;}”][vc_column_text]

Molecular Composition of the Endocannabinoid System at Glutamatergic Synapses.
Katona, I., Urbán et al. 2006.

[/vc_column_text][/vc_column_inner][/vc_row_inner][vc_column_text]

Cannabinoids and Epilepsy

[/vc_column_text][vc_separator border_width=”2″][vc_row_inner][vc_column_inner width=”1/6″][vc_single_image image=”15045″ img_size=”full” alignment=”center” style=”vc_box_shadow” onclick=”custom_link” link=”http://theroc.us/images/Agonistic%20Properties%20of%20Cannabidiol%20at%205-HT1a%20Receptors.pdf” css=”.vc_custom_1472635129860{margin-bottom: 15px !important;}”][vc_column_text]

Agonistic Properties of Cannabidiol at 5-HT1a Receptors.
Russo, E., Burnett, A., Hall, B., & Parker, K., 2005.

[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/6″][vc_single_image image=”15046″ img_size=”full” alignment=”center” style=”vc_box_shadow” onclick=”custom_link” link=”https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4301686/pdf/bph0172-0737.pdf” css=”.vc_custom_1472635333449{margin-bottom: 15px !important;}”][vc_column_text]

Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.
McPartland, J. M., Duncan, M., Di Marzo, V., & Pertwee, R. G., 2015.

[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/6″][vc_single_image image=”15047″ img_size=”full” alignment=”center” style=”vc_box_shadow” onclick=”custom_link” link=”http://www.gwpharm.com/uploads/jones-2012-cannabidiolextersanti-convulsanteffectsinanimalmodelsoftemporallobeandpartialseizures.pdf” css=”.vc_custom_1472635525198{margin-bottom: 15px !important;}”][vc_column_text]

Cannabidiol exerts anti-convulsant effects in animal models of temporal lobe and partial seizures.
Jones, N. A., Glyn, S. E., Akiyama et al., 2012.

[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/6″][vc_single_image image=”15048″ img_size=”full” alignment=”center” style=”vc_box_shadow” onclick=”custom_link” link=”http://onlinelibrary.wiley.com/store/10.1002/14651858.CD009270.pub3/asset/CD009270.pdf;jsessionid=C32BC37F93265A78535DF3F3008B8453.f01t03?v=1&t=isip7cxm&s=ab33da80c4fe58524586595cf7cf46449e11aad0&systemMessage=Wiley+Online+Library+will+be+unavailable+on+Saturday+3rd+September+2016+at+08.30+BST%2F+03%3A30+EDT%2F+15%3A30+SGT+for+5+hours+and+Sunday+4th+September+at+10%3A00+BST%2F+05%3A00+EST%2F+17%3A00+SGT+for+1+hour++for+essential+maintenance.+Apologies+for+the+inconvenience” css=”.vc_custom_1472635713295{margin-bottom: 15px !important;}”][vc_column_text]

Cannabinoids for epilepsy.
Gloss, D. and Vickrey, B., 2014.

[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/6″][vc_single_image image=”15049″ img_size=”full” alignment=”center” style=”vc_box_shadow” onclick=”custom_link” link=”http://onlinelibrary.wiley.com/doi/10.1111/epi.12610/full” css=”.vc_custom_1472635881090{margin-bottom: 15px !important;}”][vc_column_text]

The case for medical marijuana in epilepsy.
Maa, E. and Figi, P., 2014.

[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/6″][vc_single_image image=”15050″ img_size=”full” alignment=”center” style=”vc_box_shadow” onclick=”custom_link” link=”http://onlinelibrary.wiley.com/doi/10.1111/epi.12631/full” css=”.vc_custom_1472636049887{margin-bottom: 15px !important;}”][vc_column_text]

Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
Devinsky, O., Cilio, M.R., Cross, et al., 2014.

[/vc_column_text][/vc_column_inner][/vc_row_inner][vc_row_inner][vc_column_inner width=”1/6″][vc_single_image image=”15051″ img_size=”full” alignment=”center” style=”vc_box_shadow” onclick=”custom_link” link=”http://www.thelancet.com/pdfs/journals/laneur/PIIS1474-4422(15)00379-8.pdf” css=”.vc_custom_1472636284438{margin-bottom: 15px !important;}”][vc_column_text]

Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.
Devinsky, O., Marsh, E., Friedman, D. et al, 2016.

[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/6″][vc_single_image image=”16335″ img_size=”full” alignment=”center” style=”vc_box_shadow” onclick=”custom_link” link=”http://drive.google.com/a/uttbio.com/file/d/0B5GR5Qf1tz0LSUVWVV9Od3pYc28/view?usp=sharing_eidp&ts=57f5f8c5″ css=”.vc_custom_1475756494564{margin-bottom: 15px !important;}”][vc_column_text]

Epilepsy and Cannabinoids: A Literature Review.
UTT BioPharma, 2016.

[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/6″][/vc_column_inner][vc_column_inner width=”1/6″][/vc_column_inner][vc_column_inner width=”1/6″][/vc_column_inner][vc_column_inner width=”1/6″][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][/fusion_builder_column][fusion_builder_column type=”1_1″ background_position=”left top” background_color=”” border_size=”” border_color=”” border_style=”solid” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”no” center_content=”no” min_height=”none”][vc_row][vc_column][vc_column_text]

Note: This material is not for mass disclosure but intended only for the interest or benefit of students and colleagues.

[/vc_column_text][/vc_column][/vc_row][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]